THE WEIGHT IS OVER — Danish drugmaker Novo Nordisk won FDA approval Thursday for a higher dose of its weight-loss drug Wegovy — a decision FDA Commissioner Marty Makary touted on social media because ...

Get the latest federal technology news delivered to your inbox. The General Services Administration has released a draft of several changes it plans for the Multiple Award Schedule program, a ...

ARPA-H, a part of the HHS that funds biomedical and health research, is launching the program after cuts and leadership changes last year. The Trump administration shut down research programs at ...

Abstract: This letter presents the development of a multiple-input multiple-output (MIMO) coupling controller for the independent-setup variable stiffness actuator (VSA). The dynamic model of the ...

Another resurgent language is R, which returned to the top 10 in 2025, driven largely by continued growth in data science and statistical computing, Jansen said. The C language, now ranked second, and ...

REDSTONE ARSENAL, Alabama – The Capability Program Executive (CPE) Aviation, through its Utility Helicopters Project Office (UHPO), issued a Request for Information (RFI) to industry aimed at ...

In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The family of the company's co ...

The state cited Care Crossings for more than 100 breaches of state law or rules. Whistleblowers say the business has long had issues. A new state report has cited a Stillwater-area substance abuse ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...